Al-Razi Medical Company Income Statement

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	74.38	61.35	61.33	52.39	45.19
Revenue Growth (YoY)	21.24%	0.03%	17.07%	15.95%	-
Cost of Revenue	55.25	44.95	44.03	36.42	32.23
Gross Profit	19.14	16.4	17.3	15.97	12.95
Selling, General & Admin	17.62	16.02	16	13.39	10.53
Other Operating Expenses	-	-	-0.27	-	-
Operating Expenses	17.62	16.02	15.75	13.4	10.53
Operating Income	1.52	0.38	1.55	2.57	2.42
Interest Expense	-0.82	-0.51	-0.48	-0.3	-0.37
Other Non Operating Income (Expenses)	0.37	0.66	-	0.15	0.48
EBT Excluding Unusual Items	1.06	0.53	1.08	2.43	2.53
Gain (Loss) on Sale of Assets	0.01	-	0.01	-	-
Pretax Income	1.07	0.53	1.09	2.43	2.53
Income Tax Expense	0.25	0.35	0.4	0.41	0.37
Net Income	0.82	0.18	0.69	2.01	2.16
Net Income to Common	0.82	0.18	0.69	2.01	2.16
Net Income Growth	365.96%	-74.36%	-65.95%	-6.87%	-
Shares Outstanding (Basic)	2	2	2	2	2
Shares Outstanding (Diluted)	2	2	2	2	2
EPS (Basic)	0.54	0.12	0.45	1.33	1.42
EPS (Diluted)	0.54	0.12	0.45	1.33	1.42
EPS Growth	365.96%	-74.36%	-65.95%	-6.87%	-
Free Cash Flow	3.85	1.1	1	-0.64	-2.82
Free Cash Flow Per Share	2.53	0.72	0.66	-0.42	-1.86
Dividend Per Share	-	-	1.587	-	-
Gross Margin	25.73%	26.73%	28.21%	30.49%	28.67%
Operating Margin	2.04%	0.62%	2.54%	4.91%	5.36%
Profit Margin	1.10%	0.29%	1.12%	3.84%	4.79%
Free Cash Flow Margin	5.17%	1.79%	1.63%	-1.22%	-6.25%
EBITDA	3.27	2.02	2.98	3.64	3.32
EBITDA Margin	4.39%	3.30%	4.86%	6.94%	7.34%
D&A For EBITDA	1.75	1.64	1.43	1.06	0.9
EBIT	1.52	0.38	1.55	2.57	2.42
EBIT Margin	2.04%	0.62%	2.54%	4.91%	5.36%
Effective Tax Rate	23.31%	66.80%	36.82%	16.94%	14.61%
Advertising Expenses	0.13	0.1	0.27	0.09	0.08

Source: S&P Capital IQ. Standard template. Financial Sources.